Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma α1-acid glycoprotein
about
Blood group substances as potential therapeutic agents for the prevention and treatment of infection with noroviruses proving novel binding patterns in human tissues.Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma.Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation
P2860
Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma α1-acid glycoprotein
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Development of a novel system ...... in plasma α1-acid glycoprotein
@ast
Development of a novel system ...... in plasma α1-acid glycoprotein
@en
type
label
Development of a novel system ...... in plasma α1-acid glycoprotein
@ast
Development of a novel system ...... in plasma α1-acid glycoprotein
@en
prefLabel
Development of a novel system ...... in plasma α1-acid glycoprotein
@ast
Development of a novel system ...... in plasma α1-acid glycoprotein
@en
P2093
P2860
P356
P1476
Development of a novel system ...... in plasma α1-acid glycoprotein
@en
P2093
Abby R Saniabadi
Hideyuki Shimaoka
Hiroyuki Kuwano
Shin Yazawa
Takashi Hayashi
Takayuki Asao
Toyo Nishimura
P2860
P304
P356
10.1155/2013/834790
P407
P577
2013-02-13T00:00:00Z